How language can impact Alzheimer’s trials

Alzheimer; News from the web:

According to interviews with doctors, government officials and pharmaceutical companies, few Alzheimer’s studies include medical interpreters to help patients complete the specialized neuropsychological testing component required.

One of the challenges is that clinicians and researchers have strongly cautioned against using interpreters to facilitate neuropsychological testing based on clinical experiences, observations and anecdotal evidence that they affect outcomes, according to a study published in Clinical Neuropsychology.

Read all about it HERE